Cytori Therapeutics reported $24.52M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Baxter International BAX:US $ 32716M 805M
Cerus CERS:US $ 221.91M 15.59M
Cytori Therapeutics CYTX:US $ 24.52M 2.54M
Genocea Biosciences GNCA:US $ 38.79M 17.18M
Haemonetics HAE:US $ 1859.73M 28.36M
Infinity Pharmaceuticals INFI:US $ 72.58M 12.21M
Merrimack Pharmaceuticals MACK:US $ 14.64M 110K
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Northwest Biotherapeutics NWBO:US 30.66M 9.5M
Starpharma Holdings Ltd SPL:AU 67.32M 5.91M
Teva Pharmaceutical TEVA:IT 47.06B 607M